112 related articles for article (PubMed ID: 3431518)
21. Long-term therapeutic efficacy with once-daily isosorbide-5-mononitrate (Imdur).
Kendall MJ
J Clin Pharm Ther; 1990 Jun; 15(3):169-85. PubMed ID: 2195051
[No Abstract] [Full Text] [Related]
22. The rationale for nitrates in angina pectoris.
Held P; Olsson G
Can J Cardiol; 1995 Apr; 11 Suppl B():11B-13B. PubMed ID: 7728648
[TBL] [Abstract][Full Text] [Related]
23. [Efficacy and duration of action of isosorbide-5-mononitrate in the treatment of stable angina of effort. Comparison with sustained-release isosorbide dinitrate].
Lagioia R; Scrutinio D; Mangini SG; De Toma L; Accettura D; De Nicolò M; Saliani P; Preziusi N; Antuofermo F; Rizzon P
G Ital Cardiol; 1985 Mar; 15(3):299-306. PubMed ID: 4018470
[TBL] [Abstract][Full Text] [Related]
24. Dose-effect relationship amongst three different sustained-release forms of isosorbide 5-mononitrate in patients with coronary artery disease.
Kenedi P; Gathmann-Lewik U
Cardiology; 1987; 74 Suppl 1():29-33. PubMed ID: 3300975
[TBL] [Abstract][Full Text] [Related]
25. [Long-term tolerance and therapeutic coronary effect of isosorbide-5-mononitrate. Open multicenter study of ISMO 20].
Uberbacher HJ; Glocke M; Abshagen U
MMW Munch Med Wochenschr; 1983 Jan; 125(4):76-8. PubMed ID: 6402686
[No Abstract] [Full Text] [Related]
26. [Evaluation of the therapeutic efficacy of slow-release isosorbide-5-mononitrate in ischemic cardiopathy].
Schiavoni G; Bosimini E; Amico C
Cardiologia; 1987 Nov; 32(11):1293-6. PubMed ID: 3447702
[No Abstract] [Full Text] [Related]
27. [Comparative study of isosorbide dinitrates and mononitrates in patients with ischemic heart disease and stable angina pectoris caused by stenosing coronary atherosclerosis].
Lupanov VP; Alekseeva IA; Vasil'eva NN; Chotchaev KhKh; Naumov VG
Klin Med (Mosk); 2000; 78(9):52-5. PubMed ID: 11051743
[TBL] [Abstract][Full Text] [Related]
28. Can the problem of nitrate tolerance be solved?
Silber S
Z Kardiol; 1985; 74 Suppl 1():51-4. PubMed ID: 3993162
[No Abstract] [Full Text] [Related]
29. [The effect of isosorbide nitrate, isosorbide-2- and 5-mononitrate on the exertion ECG and on the hemodynamics during atrial stimulation in patients with angina pectoris].
Stauch M; Grewe N
Z Kardiol; 1979 Oct; 68(10):687-93. PubMed ID: 516844
[No Abstract] [Full Text] [Related]
30. [Effects of oral administration of subcontinuous doses of delayed-action isosorbide-5-mononitrate. Absence of tolerance].
Lai C; Onnis E; Orani E; Soro A; Pirisi R; Cherchi A
Cardiologia; 1988 Nov; 33(11):1069-74. PubMed ID: 3076514
[No Abstract] [Full Text] [Related]
31. [Changes in exercise capacity and in induced ischemia with an oral dose of 5 isosorbide mononitrate in patients with stable angina pectoris].
Martín Luengo C; Nieto Ballesteros F; Santos Rodríguez I; Diego Domínguez M; Fernández Esteban T; Avila Escribano C; Pavón Osuna P; Cascón Bueno M
An Med Interna; 1990 Jan; 7(1):24-7. PubMed ID: 2103193
[TBL] [Abstract][Full Text] [Related]
32. [A new antianginal preparation: isosorbide-5-mononitrate].
Martsevich SIu; Metelitsa VI; Slastnikova ID; Simkhaev LS; Egorov LV; Blagodatskikh SV
Kardiologiia; 1990 Oct; 30(10):44-6. PubMed ID: 2290270
[TBL] [Abstract][Full Text] [Related]
33. [Effect of isosorbide-5-mononitrate (IS-5-MN) on left ventricular hemodynamics].
Mehmel HC; Ruffmann K; Schwarz F; Manthey J; Kübler W
Med Welt; 1981 Apr; 32(14A):527-9. PubMed ID: 7242314
[No Abstract] [Full Text] [Related]
34. [The therapeutic and prophylactic use of Olicard-Retard under outpatient polyclinical conditions in stenocardia patients].
Mikhaĭlusova MP; Bart BIa; Kulikov SI; Smirnova OL; Anchipolovskaia NG; Mamtsev BN; Dergunova EN
Ter Arkh; 1997; 69(1):17-20. PubMed ID: 9163041
[TBL] [Abstract][Full Text] [Related]
35. [Randomized double-blind comparative study: glycerol trinitrate and isosorbide mononitrate].
Kayali A
Med Welt; 1983 Dec; 34(50):1441-4. PubMed ID: 6420639
[No Abstract] [Full Text] [Related]
36. [Hemodynamic changes at rest and during stress following isosorbide-5-mononitrate therapy in patients with coronary disease].
Isbary J; Doering W; Wauer B; Greding H; König E
Med Welt; 1981 Apr; 32(14A):530-4. PubMed ID: 7242315
[No Abstract] [Full Text] [Related]
37. [Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo].
Müller G; Uberbacher HJ; Glocke M
Med Welt; 1983 Mar; 34(10):321-7. PubMed ID: 6133205
[No Abstract] [Full Text] [Related]
38. Treatment of coronary heart disease with isosorbide mononitrate ('Elantan' 20).
van Hasselt M; Weiss M; Haase W
Curr Med Res Opin; 1984; 9(2):107-12. PubMed ID: 6443348
[TBL] [Abstract][Full Text] [Related]
39. [The efficacy of 2 new drug forms of isosorbide-5-mononitrate in patients with stable stenocardia of effort].
Metelitsa VI; Martsevich SIu; Kutishenko NP; Kozyreva MP; Blagodatskikh SV; Simkhaev LS; Slastnikova ID; Vakulovskaia MK
Ter Arkh; 1994; 66(8):22-5. PubMed ID: 7985147
[No Abstract] [Full Text] [Related]
40. Isosorbide-5-mononitrate--effective monotherapy in chronic stable angina.
Akhras F; Jefferies S; Jackson G
Z Kardiol; 1985; 74 Suppl 4():16-20. PubMed ID: 3938114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
